Molecular Insight Pharmaceuticals (NASDAQ: MIPI) is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the identification ...

We are introducing a new type of art using the microscope. The Molecular Expressions Pharmaceutical Gallery features photomicrographs of over 125 commonly used drugs.

Molecular Insight Pharmaceuticals (NASDAQ: MIPI) is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the identification ...

Welcome to Quantum Quantum Molecular Pharmaceuticals, Inc. (Quantum), a majority-held subsidiary of Imagin Diagnostic Centres, Inc. (IMAGIN) was formed to capitalize on lack of ...

Form (Filer) Received ( Period) 8-K: MOLECULAR INSIGHT PHARMACEUTICALS, INC. 09/26/08 (09/25/08)

Molecular Insight Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in ...

The popular Molecular Expressions Pharmaceuticals collection is now available as a Windows screen saver.

Summary of Molecular Insight Pharmaceuticals, Inc., by Richard G. Hamermesh, Edwin W. Parkinson III. Find this and other business articles and publications at Harvard Business ...

Read news articles related to Molecular Insight Pharmaceuticals, Inc. To Present At Jefferies Healthcare Conference on Boston.com

MOLECULAR INSIGHT PHARMACEUTICALS, INC.: MIPI (Nasdaq National Mkt)

Read news articles related to Molecular Insight Pharmaceuticals, Inc. Presents Three Studies on Trofex(TM) Program for Prostate Cancer Diagnosis and Staging on Boston.com

Read the Molecular Insight Pharmaceuticals Inc MIPI.O company profile at Reuters.com. ... Molecular Insight Pharmaceuticals Inc (Consolidated Issue listed on NASDAQ Global Market

Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors. - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc ...

M olecular P harmacology and B iological C hemistry is a department of the Feinberg School of Medicine at Northwestern University

Get the latest on Molecular Insight Pharmaceuticals, Inc. (MIPI) including stock quotes, interactive charts, up to date news, high quality discussion groups and more on Google ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer, will present ...

CAMBRIDGE, Mass.--(Business Wire)-- Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular ...

The article about this company has not been written yet. You could be the first person to write about this company?it's a sure thing that you'll...

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.

Molecular Insight Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript. August 13, 2008 10:00 am ET. Executives. David Barlow ? Chairman and CEO

Molecular Insight Pharmaceuticals, Inc. To Present at NewsMakers in the Biotech Industry Conference. - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc ...

Molecular Insight is a privately held, emerging biopharmaceutical company based in Cambridge, Massachusetts. The company is focused on leveraging its proprietary technology ...

Molecular Insight Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference. - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ:

Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results Wed Aug 13, 8:37 AM

Molecular Insight Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the research, development, and commercialization of molecular imaging ...

Molecular Insight Pharmaceuticals, Inc. To Present At Jefferies Healthcare Conference. - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ:

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) todayannounced that it has expanded its Board of Directors with theaddition of four industry leaders in healthcare.

Molecular Insight Pharmaceuticals, Inc. To Present at NewsMakers in the Biotech Industry Conference Wed Aug 27, 8:33 AM

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announcedtoday that David S. ... Business Wire - Press Release Molecular Insight Pharmaceuticals, Inc. To Present at ...